FOX BUSINESS NETWORK'S CHARLIE GASPARINO REPORTS VALEANT PHARAMACEUTICALS IS "ACTIVELY DISCUSSING" SELLING ITS BAUSCH AND LOMB UNIT FOX Business Network's (FBN) Charlie Gasparino reports Valeant Pharmaceuticals is "actively discussing" selling its Bausch and Lomb unit. On whether Valeant Pharmaceuticals will sell its Bausch and Lomb: "This is what we have from sources, investment bankers that are dealing with in this issue right now, that Valeant is eyeing asset sales to pay down some of its debt.